首页 > 最新文献

Drug Invention Today最新文献

英文 中文
Stability indicating spectrophotometric methods for determination of bumadizone in the presence of its alkaline degradation product 稳定性指示分光光度法测定碱降解产物中人类酮的含量
Pub Date : 2013-06-01 Epub Date: 2013-07-27 DOI: 10.1016/j.dit.2013.06.001
Hala E. Zaazaa , Nouruddin W. Ali , Maimana A. Magdy , Mohamed Abdelkawy

Objectives

Simple, selective and precise stability indicating spectrophotometric methods were adopted and validated for the quantitative determination of Bumadizone calcium semihydrate (BUM) in presence of its alkaline degradation product (DEG I).

Methods

Method A is based on the application of first derivative (1D) spectrophotometry, then measuring the amplitude of BUM at 245.4 nm. Method B depends on measuring the peak amplitude of the first derivative of the ratio spectra (1DD) at 242.6, 260 and 274 nm over a concentration range of 6–20 μg mL−1. Method C is isoabsorptive point spectrophotometry where total concentration of BUM and DEG I was calculated at their isoabsorptive point at 242.2 nm (Aiso) while DEG I concentration alone can be determined at λmax 320 nm, and then BUM concentration can be determined by subtraction. In Method D ratio subtraction spectrophotometry is applied.

Results

The four methods were found to be specific for determination BUM in presence of different concentrations of DEG I and were successfully applied for the determination of BUM in Octomotol® tablets.

Conclusion

Statistical comparison between the results obtained by applying the proposed methods and that obtained by the manufacturer one for the determination of the drug was done, and it was found that there is no significant difference between them.

目的采用一阶导数(1D)分光光度法,在245.4 nm处测定半水合布玛地酮钙(BUM)的振幅,建立了一阶导数(1D)分光光度法测定其碱性降解产物(DEG)的方法。方法B依赖于在6-20 μg mL−1的浓度范围内,在242.6、260和274 nm处测量比值光谱(1DD)一阶导数的峰值幅度。方法C为等吸收点分光光度法,在242.2 nm处计算BUM和DEG I的等吸收点总浓度(Aiso),在λmax 320 nm处单独测定DEG I浓度,然后通过相减法测定BUM浓度。方法D采用比减法分光光度法。结果4种方法均能在不同浓度的DEG I存在下特异测定BUM,并可成功应用于八tomotool®片剂中BUM的测定。结论将所建方法与生产厂家方法测定的结果进行了统计比较,两者无显著性差异。
{"title":"Stability indicating spectrophotometric methods for determination of bumadizone in the presence of its alkaline degradation product","authors":"Hala E. Zaazaa ,&nbsp;Nouruddin W. Ali ,&nbsp;Maimana A. Magdy ,&nbsp;Mohamed Abdelkawy","doi":"10.1016/j.dit.2013.06.001","DOIUrl":"10.1016/j.dit.2013.06.001","url":null,"abstract":"<div><h3>Objectives</h3><p>Simple, selective and precise stability indicating spectrophotometric methods were adopted and validated for the quantitative determination of Bumadizone calcium semihydrate (BUM) in presence of its alkaline degradation product (DEG I).</p></div><div><h3>Methods</h3><p><strong>Method A</strong> is based on the application of first derivative (<sup>1</sup>D) spectrophotometry, then measuring the amplitude of BUM at 245.4 nm. <strong>Method B</strong> depends on measuring the peak amplitude of the first derivative of the ratio spectra (<sup>1</sup>DD) at 242.6, 260 and 274 nm over a concentration range of 6–20 μg mL<sup>−1</sup>. <strong>Method C</strong> is isoabsorptive point spectrophotometry where total concentration of BUM and DEG I was calculated at their isoabsorptive point at 242.2 nm (Aiso) while DEG I concentration alone can be determined at <em>λ</em><sub>max</sub> 320 nm, and then BUM concentration can be determined by subtraction. In <strong>Method D</strong> ratio subtraction spectrophotometry is applied.</p></div><div><h3>Results</h3><p>The four methods were found to be specific for determination BUM in presence of different concentrations of DEG I and were successfully applied for the determination of BUM in Octomotol<sup>®</sup> tablets.</p></div><div><h3>Conclusion</h3><p>Statistical comparison between the results obtained by applying the proposed methods and that obtained by the manufacturer one for the determination of the drug was done, and it was found that there is no significant difference between them.</p></div>","PeriodicalId":11284,"journal":{"name":"Drug Invention Today","volume":"5 2","pages":"Pages 139-147"},"PeriodicalIF":0.0,"publicationDate":"2013-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.dit.2013.06.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88438321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Design, synthesis and biological evaluation of some novel isoniazid cyclocondensed azetidinones 几种新型异烟肼环缩合氮杂二酮的设计、合成及生物学评价
Pub Date : 2013-06-01 Epub Date: 2013-07-27 DOI: 10.1016/j.dit.2013.05.007
Karthikeyan Elumalai , Mohammed Ashraf Ali , Manogaran Elumalai , Kalpana Eluri , Sivaneswari Srinivasan , Sujit Kumar Mohanti , Anil Thota

Background

In the present study, a series of novel azetidinone derivatives synthesized because of its potent antimicrobial and antimycobacterial activity.

Method

Compounds (10a–10j) were synthesized by reacting Schiff's base of isoniazid reacted with, chloro acetyl chloride in presence of triethyl amine and 1, 4-dioxane as an efficient catalyst, analyzed for their structures. in vitro antimicrobial and antimycobacterial activity were carried out.

Results

Among the synthesized compounds, compound 10b and 10i was found to be the most potent against gram-positive bacteria Bacillus subtilis, gram-negative bacteria Escherichia coli, Mycobacterium tuberculosis CIP and M. tuberculosis H37Rv.

Conclusion

A series of novel azetidinone derivatives of biological interest were synthesized and analyzed, suggests that it an interesting compound compared to the current therapeutic agents and are considered to investigate further for the same.

本研究合成了一系列新的氮杂啶酮衍生物,因为其具有很强的抗菌和抑菌活性。方法以异烟肼希夫碱与氯乙酰氯在三乙胺和1,4 -二恶烷的催化下反应合成化合物(10a-10j),并对其结构进行分析。体外抗菌和抑菌活性测定。结果化合物10b和10i对革兰氏阳性菌枯草芽孢杆菌、革兰氏阴性菌大肠杆菌、结核分枝杆菌CIP和结核分枝杆菌H37Rv的抑制作用最强。结论合成并分析了一系列具有生物学意义的新型氮杂啶酮衍生物,与现有的治疗药物相比,它是一种令人感兴趣的化合物,值得进一步研究。
{"title":"Design, synthesis and biological evaluation of some novel isoniazid cyclocondensed azetidinones","authors":"Karthikeyan Elumalai ,&nbsp;Mohammed Ashraf Ali ,&nbsp;Manogaran Elumalai ,&nbsp;Kalpana Eluri ,&nbsp;Sivaneswari Srinivasan ,&nbsp;Sujit Kumar Mohanti ,&nbsp;Anil Thota","doi":"10.1016/j.dit.2013.05.007","DOIUrl":"10.1016/j.dit.2013.05.007","url":null,"abstract":"<div><h3>Background</h3><p>In the present study, a series of novel azetidinone derivatives synthesized because of its potent antimicrobial and antimycobacterial activity.</p></div><div><h3>Method</h3><p>Compounds (10a–10j) were synthesized by reacting Schiff's base of isoniazid reacted with, chloro acetyl chloride in presence of triethyl amine and 1, 4-dioxane as an efficient catalyst, analyzed for their structures. <em>in vitro</em> antimicrobial and antimycobacterial activity were carried out.</p></div><div><h3>Results</h3><p>Among the synthesized compounds, compound 10b and 10i was found to be the most potent against gram-positive bacteria <em>Bacillus subtilis,</em> gram-negative bacteria <em>Escherichia coli, Mycobacterium tuberculosis</em> CIP <em>and M. tuberculosis</em> H37Rv.</p></div><div><h3>Conclusion</h3><p>A series of novel azetidinone derivatives of biological interest were synthesized and analyzed, suggests that it an interesting compound compared to the current therapeutic agents and are considered to investigate further for the same.</p></div>","PeriodicalId":11284,"journal":{"name":"Drug Invention Today","volume":"5 2","pages":"Pages 100-104"},"PeriodicalIF":0.0,"publicationDate":"2013-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.dit.2013.05.007","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81671105","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Rasagiline hemitartrate: Synthesis, characterization and RP-HPLC validation for its estimation in bulk form 半酒石酸雷沙吉兰的合成、表征及原料药的RP-HPLC验证
Pub Date : 2013-06-01 Epub Date: 2013-07-27 DOI: 10.1016/j.dit.2013.05.002
Muvvala S. Sudhir , Ratnakaram Venkata Nadh

Objectives

To develop a reverse phase high performance liquid chromatographic method for validation and quantitative estimation of the synthesized drug rasagiline hemitartrate in bulk form.

Methods

Rasagiline hemitartrate was synthesized and characterized by spectral (Infrared, Proton Nuclear Magnetic Resonance and Mass) as well as elemental analysis. Chromatographic separation was conducted on Agilent TC-C18 (250 × 4.6 mm, 5 μm) column at ambient temperature using mixture of 20 mM potassium dihydrogen orthophosphate buffer (pH 7.0): methanol and acetonitrile in the ratio (30:30:40 v/v) as a mobile phase and at a flow rate of 1.0 mL/min, while UV detection was performed at 285 nm. In addition to LOD and LOQ, other analytical parameters viz., linearity, precision, accuracy, ruggedness and robustness were detected by following the ICH (International Conference on Harmonization) guidelines.

Results

The retention time for rasagiline hemitartrate was found to be 4.30 ± 0.05 min. The method was found to be linear in the range of 10–50 μg/mL. The limit of detection and quantization for rasagiline hemitartrate are found to be 0.651 and 1.972 μg/mL respectively. Analytical recovery was 100.47%. The percentage RSD for precision and accuracy of the method was found to be less than 2%. Correlation coefficient was found to be 0.9952.

Conclusion

In this study, simple, sensitive, accurate and reliable RP-HPLC method was developed and validated as per the ICH guidelines for the determination of the synthesized drug rasagiline hemitartrate in bulk form.

目的建立反相高效液相色谱法对原料药半酒石酸雷沙吉兰进行定量评价和验证。方法合成半酒石酸沙沙吉兰,并采用红外、质子核磁共振、质谱、元素分析等方法对其进行表征。色谱柱为Agilent TC-C18 (250 × 4.6 mm, 5 μm)柱,室温下,以20 mm正磷酸二氢钾缓冲液(pH 7.0):甲醇和乙腈按30:30:40 v/v的比例为流动相,流速为1.0 mL/min, 285 nm进行紫外检测。除定量限和定量限外,其他分析参数,即线性,精密度,准确度,坚固性和稳健性均按照ICH(国际协调会议)指南进行检测。结果半酒石酸雷沙吉兰的保留时间为4.30±0.05 min,在10 ~ 50 μg/mL范围内呈良好的线性关系。半酒石酸雷沙吉兰的检测限和定量限分别为0.651和1.972 μg/mL。分析回收率为100.47%。该方法精密度和准确度的RSD百分比小于2%。相关系数为0.9952。结论本研究建立了一种简便、灵敏、准确、可靠的反相高效液相色谱测定方法,并根据ICH指南进行了验证。
{"title":"Rasagiline hemitartrate: Synthesis, characterization and RP-HPLC validation for its estimation in bulk form","authors":"Muvvala S. Sudhir ,&nbsp;Ratnakaram Venkata Nadh","doi":"10.1016/j.dit.2013.05.002","DOIUrl":"10.1016/j.dit.2013.05.002","url":null,"abstract":"<div><h3>Objectives</h3><p>To develop a reverse phase high performance liquid chromatographic method for validation and quantitative estimation of the synthesized drug rasagiline hemitartrate in bulk form.</p></div><div><h3>Methods</h3><p>Rasagiline hemitartrate was synthesized and characterized by spectral (Infrared, Proton Nuclear Magnetic Resonance and Mass) as well as elemental analysis. Chromatographic separation was conducted on Agilent TC-C18 (250 × 4.6 mm, 5 μm) column at ambient temperature using mixture of 20 mM potassium dihydrogen orthophosphate buffer (pH 7.0): methanol and acetonitrile in the ratio (30:30:40 v/v) as a mobile phase and at a flow rate of 1.0 mL/min, while UV detection was performed at 285 nm. In addition to LOD and LOQ, other analytical parameters viz., linearity, precision, accuracy, ruggedness and robustness were detected by following the ICH (International Conference on Harmonization) guidelines.</p></div><div><h3>Results</h3><p>The retention time for rasagiline hemitartrate was found to be 4.30 ± 0.05 min. The method was found to be linear in the range of 10–50 μg/mL. The limit of detection and quantization for rasagiline hemitartrate are found to be 0.651 and 1.972 μg/mL respectively. Analytical recovery was 100.47%. The percentage RSD for precision and accuracy of the method was found to be less than 2%. Correlation coefficient was found to be 0.9952.</p></div><div><h3>Conclusion</h3><p>In this study, simple, sensitive, accurate and reliable RP-HPLC method was developed and validated as per the ICH guidelines for the determination of the synthesized drug rasagiline hemitartrate in bulk form.</p></div>","PeriodicalId":11284,"journal":{"name":"Drug Invention Today","volume":"5 2","pages":"Pages 133-138"},"PeriodicalIF":0.0,"publicationDate":"2013-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.dit.2013.05.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83761626","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Interactions between carvedilol and sodium valproate along with neurobehavioural co-morbidities in various epilepsy models 卡维地洛和丙戊酸钠在各种癫痫模型中与神经行为共病的相互作用
Pub Date : 2013-06-01 Epub Date: 2013-07-27 DOI: 10.1016/j.dit.2013.05.003
Radha Goel , Amit Goel

Objective

This study evaluated the effect of carvedilol (CRV) commonly used antihypertensive drugs on the antiepileptic drug sodium valproate (SVP) along with neurobehavioural co-morbidities in various models of epilepsy.

Methods

For this purpose, we used the Increasing Current Electroshock Seizure (ICES) test and Pentylenetetrazole (PTZ) test in mice. Additionally, adverse effects of combined treatment with the drugs in the Spontaneous Alternation Behavior (SAB) and rotarod were assessed. The levels of TBARS and the Reduced Glutathione (GSH) were determined in brains of mice for investigation of the oxidative stress. All drugs were administered orally.

Results

SVP (50 & 100 mg/kg) and CRV (1.25, 2.5 & 5.0 mg/kg) alone as well as in combination significantly enhanced the seizure threshold in the ICES test and PTZ test. CRV significantly increase the percentage alternation scores as compared to control group whereas combination of SVP with CRV did not affect the percentage alternation scores. In the present study, CRV and SVP alone as well as in combinations had no significant effect on motor parameters, at any of the given doses. CRV and SVP alone as well as in combination shown to inhibit the lipid peroxidation and increase in the level of GSH in brain tissue in a dose dependent manner which showed that it reduces the oxidative stress.

Conclusion

The current study suggests that CRV potentiate the anticonvulsant activity of VPA. Therefore, the observed interaction could be pharmacodynamics in nature.

目的评价常用降压药卡维地洛(CRV)对抗癫痫药物丙戊酸钠(SVP)及各种癫痫模型神经行为共病的影响。方法采用小鼠增加电流电击发作(ICES)试验和戊四唑(PTZ)试验。此外,还评估了药物联合治疗在自发交替行为(SAB)和rotarod中的不良反应。测定氧化应激小鼠脑内TBARS和还原性谷胱甘肽(GSH)水平。所有药物均口服。结果:ssvp (50 &100 mg/kg)和CRV (1.25, 2.5 &5.0 mg/kg)单独和联合显著提高癫痫发作阈值在ICES试验和PTZ试验。与对照组相比,CRV显著提高了百分比交替得分,而SVP与CRV联合使用对百分比交替得分没有影响。在本研究中,在任何给定剂量下,单独使用CRV和SVP以及联合使用CRV和SVP对运动参数没有显著影响。CRV和SVP单独或联合使用均能抑制脑组织脂质过氧化,并以剂量依赖性方式增加GSH水平,表明其可减轻氧化应激。结论CRV可增强VPA的抗惊厥活性。因此,观察到的相互作用可能是药效学性质的。
{"title":"Interactions between carvedilol and sodium valproate along with neurobehavioural co-morbidities in various epilepsy models","authors":"Radha Goel ,&nbsp;Amit Goel","doi":"10.1016/j.dit.2013.05.003","DOIUrl":"10.1016/j.dit.2013.05.003","url":null,"abstract":"<div><h3>Objective</h3><p>This study evaluated the effect of carvedilol (CRV) commonly used antihypertensive drugs on the antiepileptic drug sodium valproate (SVP) along with neurobehavioural co-morbidities in various models of epilepsy.</p></div><div><h3>Methods</h3><p>For this purpose, we used the Increasing Current Electroshock Seizure (ICES) test and Pentylenetetrazole (PTZ) test in mice. Additionally, adverse effects of combined treatment with the drugs in the Spontaneous Alternation Behavior (SAB) and rotarod were assessed. The levels of TBARS and the Reduced Glutathione (GSH) were determined in brains of mice for investigation of the oxidative stress. All drugs were administered orally.</p></div><div><h3>Results</h3><p>SVP (50 &amp; 100 mg/kg) and CRV (1.25, 2.5 &amp; 5.0 mg/kg) alone as well as in combination significantly enhanced the seizure threshold in the ICES test and PTZ test. CRV significantly increase the percentage alternation scores as compared to control group whereas combination of SVP with CRV did not affect the percentage alternation scores. In the present study, CRV and SVP alone as well as in combinations had no significant effect on motor parameters, at any of the given doses. CRV and SVP alone as well as in combination shown to inhibit the lipid peroxidation and increase in the level of GSH in brain tissue in a dose dependent manner which showed that it reduces the oxidative stress.</p></div><div><h3>Conclusion</h3><p>The current study suggests that CRV potentiate the anticonvulsant activity of VPA. Therefore, the observed interaction could be pharmacodynamics in nature.</p></div>","PeriodicalId":11284,"journal":{"name":"Drug Invention Today","volume":"5 2","pages":"Pages 87-91"},"PeriodicalIF":0.0,"publicationDate":"2013-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.dit.2013.05.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77315084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Synthesis of indazole substituted-1,3,4-thiadiazoles and their anticonvulsant activity 茚唑取代-1,3,4-噻二唑的合成及其抗惊厥活性
Pub Date : 2013-06-01 Epub Date: 2013-07-27 DOI: 10.1016/j.dit.2013.06.002
Kikkeri P. Harish , Kikkeri N. Mohana , Lingappa Mallesha

Objectives

To synthesize a new series of indazole substituted-1,3,4-thiadiazole derivatives 7(a-l) and test the anticonvulsant activity against maximal electroshock (MES) seizure model in male Wistar rats.

Methods

New compounds were synthesized by the reaction of indazole substituted-1,3,4-thiadiazoles with various sulfonyl chlorides. The purity of the compounds was confirmed on the basis of their elemental analysis. Chemical structures of all the new compounds were established by 1H NMR and mass spectral data. Anticonvulsant study was done by MES seizure model and rotorod method was employed to determine the neurotoxicity.

Results

All the compounds were synthesized in good yield. Out of twelve compounds, 7b and 7d are found to be most potent of this series. The same compounds showed no neurotoxicity at the maximum dose administered (100 mg/kg).

Conclusions

The results obtained justify the usage of these compounds from their promising anticonvulsant activity. Further studies are needed to fully characterize the toxicity and the mechanisms involved with the anticonvulsant activity and neurotoxicity of these compounds.

目的合成一种新的咪唑取代-1,3,4-噻二唑衍生物7(a- 1),并测定其对雄性Wistar大鼠最大电休克(MES)发作模型的抗惊厥活性。方法采用不同的磺酰氯与茚唑取代-1,3,4-噻二唑反应合成新化合物。根据元素分析,确定了化合物的纯度。所有新化合物的化学结构均通过1H NMR和质谱数据确定。采用MES发作模型进行抗惊厥研究,采用旋流法测定神经毒性。结果所有化合物均以较好的收率合成。在12个化合物中,7b和7d被发现是该系列中最有效的。相同的化合物在最大剂量(100 mg/kg)下没有神经毒性。结论这些化合物具有良好的抗惊厥作用,值得临床应用。需要进一步的研究来充分表征这些化合物的毒性和抗惊厥活性和神经毒性的机制。
{"title":"Synthesis of indazole substituted-1,3,4-thiadiazoles and their anticonvulsant activity","authors":"Kikkeri P. Harish ,&nbsp;Kikkeri N. Mohana ,&nbsp;Lingappa Mallesha","doi":"10.1016/j.dit.2013.06.002","DOIUrl":"10.1016/j.dit.2013.06.002","url":null,"abstract":"<div><h3>Objectives</h3><p>To synthesize a new series of indazole substituted-1,3,4-thiadiazole derivatives <strong>7(a-l)</strong> and test the anticonvulsant activity against maximal electroshock (MES) seizure model in male Wistar rats.</p></div><div><h3>Methods</h3><p>New compounds were synthesized by the reaction of indazole substituted-1,3,4-thiadiazoles with various sulfonyl chlorides. The purity of the compounds was confirmed on the basis of their elemental analysis. Chemical structures of all the new compounds were established by <sup>1</sup>H NMR and mass spectral data. Anticonvulsant study was done by MES seizure model and rotorod method was employed to determine the neurotoxicity.</p></div><div><h3>Results</h3><p>All the compounds were synthesized in good yield. Out of twelve compounds, <strong>7b</strong> and <strong>7d</strong> are found to be most potent of this series. The same compounds showed no neurotoxicity at the maximum dose administered (100 mg/kg).</p></div><div><h3>Conclusions</h3><p>The results obtained justify the usage of these compounds from their promising anticonvulsant activity. Further studies are needed to fully characterize the toxicity and the mechanisms involved with the anticonvulsant activity and neurotoxicity of these compounds.</p></div>","PeriodicalId":11284,"journal":{"name":"Drug Invention Today","volume":"5 2","pages":"Pages 92-99"},"PeriodicalIF":0.0,"publicationDate":"2013-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.dit.2013.06.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76826230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 20
In vivo study of clobetasol propionate loaded nanoemulsion for topical application in psoriasis and atopic dermatitis 负载丙酸氯倍他索纳米乳局部应用于银屑病和特应性皮炎的体内研究
Pub Date : 2013-03-01 Epub Date: 2013-05-22 DOI: 10.1016/j.dit.2013.02.001
Md. Sarfaraz Alam , Md. Sajid Ali , Nawazish Alam , Masoom Raza Siddiqui , Md. Shamim , M.M. Safhi

Objectives

Optimized formulations were subjected to various In vivo studies like anti-inflammatory activity, Nickel induced dermatitis and irritation study. Clobetasol propionate (CP) has anti-inflammatory, immunomodulatory, and antiproliferative activity. The aim of the present work was to test the hypothesis that the addition CP in nanoemulsions would result in enhancement CP delivery and leading to better antipsoriatic activity.

Materials and methods

Nanoemulsions were prepared by aqueous phase titration method, using eucalyptus oil, Tween 20, ethanol, and distilled water as the oil phase, surfactant, co-surfactant and aqueous phase, respectively.

Results and discussion

We developed a topical O/W nanoemulsion in which drug is incorporated in disperse phase of oil and evaluated its efficacy against different types of in vivo studies. It was also found that the significantly increased their anti-inflammatory activity. It was reported that CP-loaded nanoemulsion significantly increased NTPDase (Nucleoside triphosphate diphosphohydrolases) activity in lymphocytes. This membrane protein is responsible for the hydrolysis of extracellular ATP (Adenosine triphosphate) which is responsible for cell proliferation, differentiation and inflammatory processes. In vivo irritation studies did not show any irritation in spite of having high amount of surfactant.

Conclusion

On the basis of above in vivo study we conclude that developed nanoemulsion is safe for human use because it has good anti-inflammatory action and did not show any irritation to the skin. All though nanoemulsion contain high amount of surfactant in comparison to cream.

目的对优化后的配方进行抗炎活性、镍致皮炎及刺激性等体内实验研究。丙酸氯倍他索(CP)具有抗炎、免疫调节和抗增殖活性。本研究的目的是验证在纳米乳中添加CP会导致CP传递增强并导致更好的抗银屑病活性的假设。材料与方法采用水相滴定法,以桉叶油、吐温20、乙醇和蒸馏水分别为油相、表面活性剂、助表面活性剂和水相制备纳米乳液。我们开发了一种局部油/水纳米乳,将药物掺入油的分散相中,并通过不同类型的体内研究评估了其疗效。研究还发现,它们的抗炎活性显著增加。据报道,载cp纳米乳显著提高淋巴细胞ntpase(核苷三磷酸二磷酸水解酶)活性。这种膜蛋白负责胞外ATP(三磷酸腺苷)的水解,而三磷酸腺苷负责细胞增殖、分化和炎症过程。体内刺激研究显示,尽管表面活性剂的含量很高,但没有任何刺激。结论在上述体内实验的基础上,所研制的纳米乳具有良好的抗炎作用,对皮肤无刺激性,可安全用于人体。与乳霜相比,纳米乳含有大量的表面活性剂。
{"title":"In vivo study of clobetasol propionate loaded nanoemulsion for topical application in psoriasis and atopic dermatitis","authors":"Md. Sarfaraz Alam ,&nbsp;Md. Sajid Ali ,&nbsp;Nawazish Alam ,&nbsp;Masoom Raza Siddiqui ,&nbsp;Md. Shamim ,&nbsp;M.M. Safhi","doi":"10.1016/j.dit.2013.02.001","DOIUrl":"10.1016/j.dit.2013.02.001","url":null,"abstract":"<div><h3>Objectives</h3><p>Optimized formulations were subjected to various <em>In vivo</em> studies like anti-inflammatory activity, Nickel induced dermatitis and irritation study. Clobetasol propionate (CP) has anti-inflammatory, immunomodulatory, and antiproliferative activity. The aim of the present work was to test the hypothesis that the addition CP in nanoemulsions would result in enhancement CP delivery and leading to better antipsoriatic activity.</p></div><div><h3>Materials and methods</h3><p>Nanoemulsions were prepared by aqueous phase titration method, using eucalyptus oil, Tween 20, ethanol, and distilled water as the oil phase, surfactant, co-surfactant and aqueous phase, respectively.</p></div><div><h3>Results and discussion</h3><p>We developed a topical O/W nanoemulsion in which drug is incorporated in disperse phase of oil and evaluated its efficacy against different types of <em>in vivo</em> studies. It was also found that the significantly increased their anti-inflammatory activity. It was reported that CP-loaded nanoemulsion significantly increased NTPDase (Nucleoside triphosphate diphosphohydrolases) activity in lymphocytes. This membrane protein is responsible for the hydrolysis of extracellular ATP (Adenosine triphosphate) which is responsible for cell proliferation, differentiation and inflammatory processes. <em>In vivo</em> irritation studies did not show any irritation in spite of having high amount of surfactant.</p></div><div><h3>Conclusion</h3><p>On the basis of above <em>in vivo</em> study we conclude that developed nanoemulsion is safe for human use because it has good anti-inflammatory action and did not show any irritation to the skin. All though nanoemulsion contain high amount of surfactant in comparison to cream.</p></div>","PeriodicalId":11284,"journal":{"name":"Drug Invention Today","volume":"5 1","pages":"Pages 8-12"},"PeriodicalIF":0.0,"publicationDate":"2013-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.dit.2013.02.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90051230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 49
Antibacterial study of silver doped zinc oxide nanoparticles against Staphylococcus aureus and Bacillus subtilis 银掺杂氧化锌纳米颗粒对金黄色葡萄球菌和枯草芽孢杆菌的抑菌研究
Pub Date : 2013-03-01 Epub Date: 2013-05-22 DOI: 10.1016/j.dit.2013.03.007
Neha Sharma , Jitender Kumar , Shaveta Thakur , Shruti Sharma , Vikas Shrivastava

Objectives

The present study has been undertaken to synthesize silver doped zinc oxide nanoparticles, with pharmaceutical importance. The synthesized particles have been evaluated to study the effect of silver doping on grain size and further on antibacterial activities against the microorganisms Bacillus subtilis and Staphylococcus aureus.

Methods

Silver doped zinc oxide nanoparticles were prepared by the solution route spin-coating process, using zinc acetate (Zn(CH3COO)2.2H2O) and silver nitrate (AgNO3) as host and dopant precursors respectively. The antibacterial activity of the silver doped zinc oxide were studied against S. auerus and B. subtilis via using agar well diffusion method.

Results & discussion

: The structure of the powder samples was analyzed by X-ray diffraction (XRD). The effect of silver doping on grain size and further on antibacterial activity against the microorganisms B. subtilis and S. auerus is discussed.

Conclusion

It was clear from X-ray investigations that its structure is wurtzite type and that an increase in Ag-doping resulted in decrease in the grain size of the ZnO nanoparticles. Antimicrobial study against the microorganisms B. subtilis and S. auerus shows that in case of S. auerus the MIC varies with increase in Ag content but in case of B. subtilis the MIC remained constant for all concentration of Ag.

目的制备银掺杂氧化锌纳米颗粒,具有重要的药学意义。对合成的颗粒进行了评价,以研究银掺杂对颗粒尺寸的影响,并进一步研究了对枯草芽孢杆菌和金黄色葡萄球菌的抗菌活性。方法以醋酸锌(Zn(CH3COO)2.2H2O)为主体,硝酸银(AgNO3)为掺杂前驱体,采用溶液路线旋涂法制备银掺杂氧化锌纳米颗粒。采用琼脂孔扩散法研究了银掺杂氧化锌对金黄色葡萄球菌和枯草芽孢杆菌的抑菌活性。结果,讨论:用x射线衍射(XRD)分析了粉末样品的结构。讨论了银掺杂对颗粒尺寸及对枯草芽孢杆菌和金黄色葡萄球菌抑菌活性的影响。结论x射线研究表明其结构为纤锌矿型,ag掺杂量的增加导致ZnO纳米颗粒尺寸的减小。对枯草芽孢杆菌和金黄色葡萄球菌的抗菌研究表明,金黄色葡萄球菌的MIC随银含量的增加而变化,而枯草芽孢杆菌的MIC在所有银浓度下都保持不变。
{"title":"Antibacterial study of silver doped zinc oxide nanoparticles against Staphylococcus aureus and Bacillus subtilis","authors":"Neha Sharma ,&nbsp;Jitender Kumar ,&nbsp;Shaveta Thakur ,&nbsp;Shruti Sharma ,&nbsp;Vikas Shrivastava","doi":"10.1016/j.dit.2013.03.007","DOIUrl":"10.1016/j.dit.2013.03.007","url":null,"abstract":"<div><h3>Objectives</h3><p>The present study has been undertaken to synthesize silver doped zinc oxide nanoparticles, with pharmaceutical importance. The synthesized particles have been evaluated to study the effect of silver doping on grain size and further on antibacterial activities against the microorganisms <em>Bacillus subtilis</em> and <em>Staphylococcus aureus</em>.</p></div><div><h3>Methods</h3><p>Silver doped zinc oxide nanoparticles were prepared by the solution route spin-coating process, using zinc acetate (Zn(CH<sub>3</sub>COO)<sub>2</sub>.2H<sub>2</sub>O) and silver nitrate (AgNO<sub>3</sub>) as host and dopant precursors respectively. The antibacterial activity of the silver doped zinc oxide were studied against <em>S. auerus</em> and <em>B. subtilis</em> via using agar well diffusion method.</p></div><div><h3>Results &amp; discussion</h3><p>: The structure of the powder samples was analyzed by X-ray diffraction (XRD). The effect of silver doping on grain size and further on antibacterial activity against the microorganisms <em>B. subtilis</em> and <em>S. auerus</em> is discussed.</p></div><div><h3>Conclusion</h3><p>It was clear from X-ray investigations that its structure is wurtzite type and that an increase in Ag-doping resulted in decrease in the grain size of the ZnO nanoparticles. Antimicrobial study against the microorganisms <em>B. subtilis</em> and <em>S. auerus</em> shows that in case of <em>S. auerus</em> the MIC varies with increase in Ag content but in case of <em>B. subtilis</em> the MIC remained constant for all concentration of Ag.</p></div>","PeriodicalId":11284,"journal":{"name":"Drug Invention Today","volume":"5 1","pages":"Pages 50-54"},"PeriodicalIF":0.0,"publicationDate":"2013-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.dit.2013.03.007","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91540178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 97
Probiotics in aquaculture 水产养殖中的益生菌
Pub Date : 2013-03-01 Epub Date: 2013-05-22 DOI: 10.1016/j.dit.2013.03.003
Priyadarshini Pandiyan , Deivasigamani Balaraman , Rajasekar Thirunavukkarasu , Edward Gnana Jothi George , Kumaran Subaramaniyan , Sakthivel Manikkam , Balamurugan Sadayappan

Aquaculture is the world's fastest growing food production sector. However, fish culture is currently suffering from serious losses due to infectious diseases. The use of antimicrobial drugs, pesticides and disinfectant in aquaculture disease prevention and growth promotion has led to the evolution of resistant strains of bacteria. Thus, the research into the use of probiotics for aquaculture is increasing with the demand for environment – friendly sustainable aquaculture. The benefits of such supplements include improved feed value, enzymatic contribution to digestion, inhibition of pathogenic microorganisms, anti-mutagenic and anti-carcinogenic activity, and increased immune response. These probiotics are harmless bacteria that help the well being of the host animal and contribute, directly or indirectly to protect the host animal against harmful bacterial pathogens. The use of probiotics in aquaculture has just begun, due to the fact that gastrointestinal microbiota of aquatic organisms has been poorly characterized, and their effects are not studied extensively. This review summarizes and evaluates brief knowledge about the probiotic organism, the action of probiotic in fish culture and the safety evaluation of probiotics in aquaculture.

水产养殖是世界上增长最快的粮食生产部门。然而,由于传染病,鱼类养殖目前正遭受严重损失。抗菌药物、农药和消毒剂在水产养殖疾病预防和促进生长中的使用导致了耐药菌株的进化。因此,随着环境友好型可持续水产养殖的需求,益生菌在水产养殖中的应用研究日益增多。这种补充剂的好处包括提高饲料价值,促进消化,抑制病原微生物,抗诱变和抗癌活性,以及增强免疫反应。这些益生菌是无害的细菌,有助于宿主动物的健康,并有助于直接或间接地保护宿主动物免受有害细菌病原体的侵害。益生菌在水产养殖中的应用才刚刚开始,由于对水生生物胃肠道微生物群的研究还不充分,对其作用的研究也不广泛。本文对益生菌生物、益生菌在鱼类养殖中的作用以及益生菌在水产养殖中的安全性评价等方面的知识进行了综述和评价。
{"title":"Probiotics in aquaculture","authors":"Priyadarshini Pandiyan ,&nbsp;Deivasigamani Balaraman ,&nbsp;Rajasekar Thirunavukkarasu ,&nbsp;Edward Gnana Jothi George ,&nbsp;Kumaran Subaramaniyan ,&nbsp;Sakthivel Manikkam ,&nbsp;Balamurugan Sadayappan","doi":"10.1016/j.dit.2013.03.003","DOIUrl":"10.1016/j.dit.2013.03.003","url":null,"abstract":"<div><p>Aquaculture is the world's fastest growing food production sector. However, fish culture is currently suffering from serious losses due to infectious diseases. The use of antimicrobial drugs, pesticides and disinfectant in aquaculture disease prevention and growth promotion has led to the evolution of resistant strains of bacteria. Thus, the research into the use of probiotics for aquaculture is increasing with the demand for environment – friendly sustainable aquaculture. The benefits of such supplements include improved feed value, enzymatic contribution to digestion, inhibition of pathogenic microorganisms, anti-mutagenic and anti-carcinogenic activity, and increased immune response. These probiotics are harmless bacteria that help the well being of the host animal and contribute, directly or indirectly to protect the host animal against harmful bacterial pathogens. The use of probiotics in aquaculture has just begun, due to the fact that gastrointestinal microbiota of aquatic organisms has been poorly characterized, and their effects are not studied extensively. This review summarizes and evaluates brief knowledge about the probiotic organism, the action of probiotic in fish culture and the safety evaluation of probiotics in aquaculture.</p></div>","PeriodicalId":11284,"journal":{"name":"Drug Invention Today","volume":"5 1","pages":"Pages 55-59"},"PeriodicalIF":0.0,"publicationDate":"2013-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.dit.2013.03.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77817176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 134
In vitro antiviral and cytotoxic screening of methanolic extract of Cassia auriculata flowers in HeLa, Vero, CRFK and HEL cell lines 黑木香花甲醇提取物对HeLa、Vero、CRFK和HEL细胞系的体外抗病毒和细胞毒性筛选
Pub Date : 2013-03-01 Epub Date: 2013-05-22 DOI: 10.1016/j.dit.2013.03.001
Saravanakumar Arthanari , Jayachandran Vanitha , Venkateshwaran Krishnaswami , Ponnusamy Renukadevi , Karthikeyan Deivasigamani , Eric De Clercq

Background

To investigate the in vitro antiviral and cytotoxic activities of methanolic extract of Cassia auriculata flowers in HeLa, Vero, CRFK and HEL Cell lines.

Methods

Polarity based cold maceration method was adopted for the extraction of flowers and the antiviral activity was assessed against herpes simplex-1 and 2, vaccinia, vesicular stomatitis, cox sackie, respiratory syncytical, feline corona, feline herpes, para influenza, reo-1, sindbis and punta toro viruses in different cell lines, such as Hel, HeLa, Crandell Reus feline kidney and Vero cell cultures. In parallel the cytotoxicity was evaluated by MTT assay method.

Results

The methanolic extract possesses the strongest antiviral activity against herpes simplex-1(EC50 = 50 μg/ml) and 2 (EC50 = 45 μg/ml) viruses and moderate activity for remaining viruses (EC50 = >100 μg/ml). The cytotoxicity results revealed that the extracts exhibited cytotoxicity above the range of 100 μg/ml.

Conclusion

The tested methanolic extract displayed an important source of anti-herpetic compound against the double stranded DNA enveloped Herpes simplex virus (HSV-1 and II), further studies are needed to identify the exact compound for their antimicrobial action.

背景研究黑木香花甲醇提取物对HeLa、Vero、CRFK和HEL细胞的体外抗病毒和细胞毒活性。方法采用极性冷浸法提取花中的单纯性疱疹病毒1型和2型、牛痘病毒、水泡性口炎病毒、考氏萨奇病毒、呼吸道合胞病毒、猫冠病毒、猫疱疹病毒、para流感病毒、reo-1病毒、sindbis病毒和punta toro病毒对不同细胞系(如HeLa、HeLa、Crandell Reus猫肾细胞和Vero细胞)的抗病毒活性。同时用MTT法测定细胞毒性。结果甲醇提取物对单纯疱疹病毒1型(EC50 = 50 μg/ml)和2型(EC50 = 45 μg/ml)具有较强的抗病毒活性,对其余病毒(EC50 = 100 μg/ml)具有中等的抗病毒活性。细胞毒性实验结果显示,提取物在100 μg/ml以上具有细胞毒性。结论甲醇提取物是抗单纯性疱疹病毒(HSV-1和hsv - II)的重要化合物来源,其抗菌作用有待进一步研究。
{"title":"In vitro antiviral and cytotoxic screening of methanolic extract of Cassia auriculata flowers in HeLa, Vero, CRFK and HEL cell lines","authors":"Saravanakumar Arthanari ,&nbsp;Jayachandran Vanitha ,&nbsp;Venkateshwaran Krishnaswami ,&nbsp;Ponnusamy Renukadevi ,&nbsp;Karthikeyan Deivasigamani ,&nbsp;Eric De Clercq","doi":"10.1016/j.dit.2013.03.001","DOIUrl":"10.1016/j.dit.2013.03.001","url":null,"abstract":"<div><h3>Background</h3><p>To investigate the <em>in vitro</em> antiviral and cytotoxic activities of methanolic extract of <em>Cassia auriculata</em> flowers in HeLa, Vero, CRFK and HEL Cell lines.</p></div><div><h3>Methods</h3><p>Polarity based cold maceration method was adopted for the extraction of flowers and the antiviral activity was assessed against herpes simplex-1 and 2, vaccinia, vesicular stomatitis, cox sackie, respiratory syncytical, feline corona, feline herpes, para influenza, reo-1, sindbis and punta toro viruses in different cell lines, such as Hel, HeLa, Crandell Reus feline kidney and Vero cell cultures. In parallel the cytotoxicity was evaluated by MTT assay method.</p></div><div><h3>Results</h3><p>The methanolic extract possesses the strongest antiviral activity against herpes simplex-1(EC<sub>50</sub> = 50 μg/ml) and 2 (EC<sub>50</sub> = 45 μg/ml) viruses and moderate activity for remaining viruses (EC<sub>50</sub> = &gt;100 μg/ml). The cytotoxicity results revealed that the extracts exhibited cytotoxicity above the range of 100 μg/ml.</p></div><div><h3>Conclusion</h3><p>The tested methanolic extract displayed an important source of anti-herpetic compound against the double stranded DNA enveloped Herpes simplex virus (HSV-1 and II), further studies are needed to identify the exact compound for their antimicrobial action.</p></div>","PeriodicalId":11284,"journal":{"name":"Drug Invention Today","volume":"5 1","pages":"Pages 28-31"},"PeriodicalIF":0.0,"publicationDate":"2013-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.dit.2013.03.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84465754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Compressed glyceryl monostearate based biodegradable implant of Gentamicin using melt granulation technique: In vitro evaluation & biocompatibility in animals 基于熔融造粒技术的压缩单硬脂酸甘油可生物降解庆大霉素植入物:体外评价及动物生物相容性
Pub Date : 2013-03-01 Epub Date: 2013-05-22 DOI: 10.1016/j.dit.2013.03.006
Ashish Y. Pawar , Kiran B. Erande , Deepak D. Sonawane , Vikas R. Asawale , Yogesh S. Harak , Deelip V. Derle

Objective

Osteomyelitis is a multibacterial bone infection which is still remains challenging and difficult to treat, despite of advances in antibiotics and new operative techniques. Present study aims at formulating Gentamicin implants in treatment of Osteomyelitis & other bone infections using glyceryl monostearate (GMS) matrices as a carrier.

Methods

Gentamicin implants were prepared by using combination of glyceryl monostearate and poly ethylene glycol as hydrophobic biodegradable sustained release matrices along with different percentage of Sorbitol and Tween80 as erosion enhancers. Several formulations were prepared (K1–K7) by melt granulation followed by compression to form disc shaped implants. The prepared formulations were evaluated for different in vitro parameters & optimized formulation was subjected to in vivo study.

Results & discussion

Formulation K4 shows excellent cumulative drug release profile and it does not completely lose its physical shape even after 28 days thus this formulation conclude to be optimum formulation among the all GMS based implant formulations. Also optimized GMS based implant does not show any severe signs of inflammation and other foreign body reactions in laboratory animals, thus it was concluded that GMS based implant have acceptable biological compatibility even after 28 days.

Conclusion

Therefore from this study it is proved that, the glyceryl monostearate based implants have potential to retard the drug release for more than five weeks in the treatment of osteomyelitis & bone infections.

目的骨髓炎是一种多细菌骨感染,尽管抗生素和新的手术技术取得了进展,但治疗仍然具有挑战性和难度。本研究旨在研制庆大霉素植入物治疗骨髓炎。以单硬脂酸甘油酯(GMS)基质为载体的其他骨感染。方法以单硬脂酸甘油酯和聚乙二醇为疏水可生物降解缓释基质,不同比例的山梨醇和吐温80为促蚀蚀剂,制备庆大霉素植入物。几种配方(K1-K7)通过熔融造粒,然后压缩形成圆盘状植入物。对制备的制剂进行了不同体外参数的评价;优化后的配方进行了体内实验。结果,制剂K4表现出优异的累积药物释放谱,即使在28天后也不会完全失去其物理形状,因此该制剂被认为是所有基于GMS的植入制剂中的最佳制剂。优化后的GMS植入物在实验动物中没有出现任何严重的炎症迹象和其他异物反应,因此GMS植入物在28天后仍具有可接受的生物相容性。结论单硬脂酸甘油酯植入体治疗骨髓炎有延缓药物释放5周以上的潜力;骨感染。
{"title":"Compressed glyceryl monostearate based biodegradable implant of Gentamicin using melt granulation technique: In vitro evaluation & biocompatibility in animals","authors":"Ashish Y. Pawar ,&nbsp;Kiran B. Erande ,&nbsp;Deepak D. Sonawane ,&nbsp;Vikas R. Asawale ,&nbsp;Yogesh S. Harak ,&nbsp;Deelip V. Derle","doi":"10.1016/j.dit.2013.03.006","DOIUrl":"10.1016/j.dit.2013.03.006","url":null,"abstract":"<div><h3>Objective</h3><p>Osteomyelitis is a multibacterial bone infection which is still remains challenging and difficult to treat, despite of advances in antibiotics and new operative techniques. Present study aims at formulating Gentamicin implants in treatment of Osteomyelitis &amp; other bone infections using glyceryl monostearate (GMS) matrices as a carrier.</p></div><div><h3>Methods</h3><p>Gentamicin implants were prepared by using combination of glyceryl monostearate and poly ethylene glycol as hydrophobic biodegradable sustained release matrices along with different percentage of Sorbitol and Tween80 as erosion enhancers. Several formulations were prepared (K1–K7) by melt granulation followed by compression to form disc shaped implants. The prepared formulations were evaluated for different <em>in vitro</em> parameters &amp; optimized formulation was subjected to <em>in vivo</em> study.</p></div><div><h3>Results &amp; discussion</h3><p>Formulation K4 shows excellent cumulative drug release profile and it does not completely lose its physical shape even after 28 days thus this formulation conclude to be optimum formulation among the all GMS based implant formulations. Also optimized GMS based implant does not show any severe signs of inflammation and other foreign body reactions in laboratory animals, thus it was concluded that GMS based implant have acceptable biological compatibility even after 28 days.</p></div><div><h3>Conclusion</h3><p>Therefore from this study it is proved that, the glyceryl monostearate based implants have potential to retard the drug release for more than five weeks in the treatment of osteomyelitis &amp; bone infections.</p></div>","PeriodicalId":11284,"journal":{"name":"Drug Invention Today","volume":"5 1","pages":"Pages 39-49"},"PeriodicalIF":0.0,"publicationDate":"2013-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.dit.2013.03.006","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74159257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Drug Invention Today
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1